ANIX Anixa: Utang jangka cendhak perusahaan

Anixa Biosciences, Inc. (ANIX) develops advanced cell therapy methods and anti-tumor vaccines. This chart of current share prices reflects the asset's dynamics, where the indicator stands at 0.00. Business revenues are based on the transfer of intellectual property rights and commercialization payments for drugs. Meanwhile, biomaterial delivery supply chains are fully optimized, eliminating disruptions in the conduct of medical tests.

This indicator captures the total liabilities of Anixa Biosciences, Inc. (ANIX) with a maturity of less than twelve months. The trend of this metric determines current liquidity and the resilience of the capital structure to external shocks. By analyzing the total amount of short-term debt, an investor assesses the risk of working capital deficits. For the biotechnology sector, debt control is critical while awaiting the results of anti-cancer vaccine trials. A stable balance of liabilities enhances the company's attractiveness as a potential acquisition target.